trans-Clovamide,
UNII-973626KV9L,
973626KV9L,
53755-02-5,
N-trans-Caffeoy-L-dopa,
N-[3',4'-Dihydroxy-(E)-cinnamoyl]-3-hydroxy-L-tyrosine,
N-(E)-Caffeoyl-L-dihydroxyphenylalanine,
AC1O6U0B,
N-trans-Caffeoyl-3,4-dihydroxy-L-phenylalanine,
CHEMBL241190,
MEGxp0_001180,
N-[3 inverted exclamation mark ,4 inverted exclamation mark -Dihydroxy-(E)-cinnamoyl]-3-hydroxy-L-tyrosine,
ZINC3649853,
L-Tyrosine, N-((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)-3-hydroxy-,
L-Tyrosine, N-(3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)-3-hydroxy-, (E)-,
L-Tyrosine, N-((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)-3-hydroxy-,
(-)-n-[3',4'-dihydroxy-(e)-cinnamoyl]-3-hydroxy-l-tyrosine,
N-[3rsquo,4rsquo-Dihydroxy-(E)-cinnamoyl]-3-hydroxy-L-tyrosine,
(2S)-3-(3,4-Dihydroxyphenyl)-2-[[3-(3,4-dihydroxyphenyl)propenoyl]amino]propanoic acid,
N-[(2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propen-1-yl]-3-hydroxy-L-tyrosine,
(2S)-3-(3,4-dihydroxyphenyl)-2-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]propanoic acid,
NCGC00385443-01!(2S)-3-(3,4-dihydroxyphenyl)-2-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]propanoic acid,
Clovamide,
CID6506968,
N-[3,4-Dihydroxy-(E)-cinnamoyl]-3-hydroxy-L-tyrosine,